Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02714413 · ClinicalTrials.gov registry record · Phase 2
Effect of D-allulose in Addition to Oral Sucrose Load
A Phase 2 study of Blood Glucose, sponsored by University of Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT02714413 is a Phase 2 study of Blood Glucose that has completed, run by University of Florida. The registered enrollment target is 50 participants, roughly in line with the 50-participant average among 4 other Blood Glucose trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT02714413, a Phase 2 study of Blood Glucose, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Individuals in the United States now consume a substantial proportion of their total energy as added sugars. The consumption of caloric sweeteners has been steadily increasing over the last four decades. The potential health consequences of this practice have been subject to considerable debate. In addition to weight gain, higher consumption of sugar-sweetened beverages is associated with development of metabolic syndrome and type 2 diabetes. These findings support the current dietary guidelines that encourage consumers to limit their intake of added sugars. There is a need for a sugar substitute that is safe, palatable and has favorable effects on energy metabolism and overall glucose homeostasis. One such sugar is possibly D-allulose also referred to in the literature as D-psicose. The present proposal is to address the efficacy of D-allulose in reducing postprandial blood glucose level in a random sample of Caucasian and African American population. Specifically the effect of D-allulose ingestion on the glucose and insulin response to a standardized oral glucose load will be studied.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT D-allulose
- DIETARY_SUPPLEMENT sucrose
Study Locations (1)
Florida
- University of Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02714413
The ClinicalTrials.gov registry entry for NCT02714413 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 50-participant average among 4 other Blood Glucose trials with a reported enrollment target. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blood Glucose appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02714413 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02714413 about?
NCT02714413 is a clinical study titled "Effect of D-allulose in Addition to Oral Sucrose Load". Individuals in the United States now consume a substantial proportion of their total energy as added sugars. The consumption of caloric sweeteners has been steadily increasing over the last four decades. The potential health consequences of this practice have been subject to considerable debate. In ...
What is the current status of trial NCT02714413?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2016-08. Estimated completion is 2017-06-30.
What conditions does trial NCT02714413 study?
This clinical trial studies the following conditions: Blood Glucose.
What interventions are being tested in trial NCT02714413?
The interventions under investigation include: Placebo (OTHER), D-allulose (DIETARY_SUPPLEMENT), sucrose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02714413?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02714413 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Glucose
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Postprandial Response to Fruit Juice
RECRUITING · NA
-
Barley and Rice Mixture Effects on Blood Glucose
COMPLETED · NA
-
Clinical Study of the Intravenous Blood Glucose System in Hospitalized Adult Elective or Non-Emergent Surgery and Medical/Surgical Intensive Care Unit Patients
COMPLETED
-
A Randomized, Crossover Study to Assess the Effects of Dietary Fiber-containing Bars on Glucose and Insulin Responses
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.